Wei-Shu Lu

This inventor holds 8 USPTO granted patents and 5 published patent applications, plus 6 CIPO patents and 3 EPO patents. Top assignee: Twi Biotechnology, Inc.. Active years: 2013-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wei-Shu Lu. Retrieved from https://idiyas.com/inventor/wei-shu-lu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 5)

% Patents Active = 62.5

CIPO Patents = 6 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 10)

Average Co-Inventor Count = 4.4

ph-index = 1

Location History:

Tucheng, TW (2013)
Taipei, TW (2017 - 2019)
New Taipei, TW (2014 - 2020)

Company Filing History:

8 out of 12

Twi Biotechnology, Inc.

patents

Years Active: 2013-2020

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10675260 - Methods and pharmaceutical compositions for preventing or treating immunoinflammatory dermal disorders (2020-06-09),

2. 10512625 - Diacerein or rhein topical formulations and uses thereof (2019-12-24),

3. 10195170 - Methods for inhibiting expression of ASC, expression of NLRP3, and/or formation of NLRP3 inflammasome complex using diacerein or its analogs (2019-02-05),

4. 10154984 - Diacerein or Rhein topical formulations and uses thereof (2018-12-18),

5. 9744131 - Diacerein or rhein topical formulations and uses thereof (2017-08-29),

6. 8865689 - Methods and compositions for treating hyperuricemia and metabolic disorders associated with hyperuricemia (2014-10-21),

7. 8846758 - Methods of decreasing glycosylated hemoglobin in patients with dyslipidemia (2014-09-30),

8. 8536152 - Methods of using diacerein as an adjunctive therapy for diabetes (2013-09-17),

Title: Innovator Spotlight: Wei-Shu Lu

Introduction

Wei-Shu Lu is a remarkable inventor based in New Taipei, Taiwan. He has made significant contributions to the field of pharmaceutical sciences, holding a total of 8 patents. His innovative work primarily focuses on developing methods and compositions to address immunoinflammatory dermal disorders, showcasing his dedication to improving healthcare.

Latest Patents

Lu's latest patents include groundbreaking advancements in treating skin conditions. One notable patent is for "Methods and pharmaceutical compositions for preventing or treating immunoinflammatory dermal disorders," which details an effective method and composition for addressing these complex conditions. Additionally, he holds a patent titled "Diacerein or rhein topical formulations and uses thereof," which describes a topical pharmaceutical composition containing diacerein and/or its analogs and outlines methods for treating various diseases with this formulation.

Career Highlights

Wei-Shu Lu currently contributes his expertise at Twi Biotechnology, Inc., where he engages in pioneering research and development efforts in the pharmaceutical sector. His dedication to innovation has played a crucial role in the advancement of therapeutic options for patients suffering from skin disorders.

Collaborations

Throughout his career, Lu has worked alongside accomplished colleagues, including Chih-Kuang Chen and Carl Oscar Brown, III. These collaborations highlight the importance of teamwork in driving forward the boundaries of pharmaceutical research and development.

Conclusion

Wei-Shu Lu exemplifies the spirit of innovation in the pharmaceutical industry. His extensive patent portfolio and collaborative efforts illustrate his commitment to enhancing treatment options for immunoinflammatory conditions, making a lasting impact on healthcare.

Profile summary based on public USPTO records.